Khiron Life Sciences
Manufacturing · Canada · 201-500 Employees
View Company Info for Free
Overview
Headquarters
100 King St W Ste 1600, Toronto, Ontario...Phone Number
(757) 462-6310Website
www.khiron.caRevenue
$11.8 MillionStock Symbol
KHRNIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Khiron Life Sciences
Khiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health centres and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructure to drive prescriptions and brand loyalty with patients worldwide. The Company has a sales presence in Colombia, Peru, Germany and the UK, and is positioned to commence sales in Mexico and Brazil in 2021. The Company is led by Co-founder and Chief Executive Officer, Alvaro Torres, together with an experienced and diverse executive team and Board of Directors. The company was founded in 2012 and is headquartered in Bogota, Colombia.Explore more
Khiron Life Sciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Khiron Life Sciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Khiron Life Sciences is spiking on competitors!
Click to see if Khiron Life Sciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when Khiron Life Sciences launches new products
Khiron Life Sciences, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Khiron Life Sciences has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Khiron Life Sciences recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Khiron Life Sciences
Funding: Get notified immidiatlly once Khiron Life Sciences has new funding data
Recommended Actions
Reach out to Masked Content who joined Khiron Life Sciences as Masked Content
Find more new buyers
Compare Similar Companies to Khiron Life Sciences
Compare insights from companies similar to Khiron Life Sciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Khiron Life Sciences
$11.8M
201-500
Public
$30M
2012
ÁM
Álvaro Madiedo GaviriaDirector, Financial Planning & Analysis
Company Profile Activity
Activity Insights
Khiron Life Sciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Khiron Life Sciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Khiron Life Sciences.
Khiron Life Sciences financials insights
Gather financial insights about Khiron Life Sciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$14.5M
2021
Stock Offering
$12.3M
2022
Stock Offering
$3.2M
Khiron Life Sciences Tech Stack
A closer look at the technologies used by Khiron Life Sciences
Most Recent Scoops
Left Company
Executive Move
New Hire
Executive Move
Earnings
Earnings
Left Company
Executive Move
New Hire
Executive Move
Khiron Life Sciences News & Media
Khiron Life Sciences Announces Update to the Proposed Sale of Its European Business
Toronto, Ontario--(Newsfile Corp. - November 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTC Pink: KHRNF) ("Khiron" or the "Company") today announced that the Company and 2518542 Alberta Ltd., a company controlled by Avonlea Drewry Holdings Inc. (the "Purchaser"), have entered into an amended and restated share purchase agreement (the "Restated Purchase Agreement") dated November 15, 2023, providing for the purchase and sale of the Company's European subsidiaries. Under the terms of theKhiron Life Sciences Agrees to $500,000 Secured Deposit
Toronto, Ontario--(Newsfile Corp. - June 5, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) ("Khiron" or the "Company") announced today that the Company has agreed to a $500,000 non-interesting bearing refundable deposit from 2518542 Alberta Ltd. ("251"), a company controlled by Avonlea-Drewry Holdings Inc., to be secured by all of Khiron's present and after-acquired property pursuant to a general security agreement and a pledge of Khiron's shares in its subsidiaries, Pharmadrug..KHIRON LIFE SCIENCES ANNOUNCES CEASE TRADE ORDER
Khiron Life Sciences Corp. ("Khiron" or the "Company") (TSXV: KHRN) (OTCQX: KHRNF) announced today that, further to its press release dated April 17, 2023, the Ontario Securities Commission (the "OSC") has denied the Company's application for a management cease trade order (the "MCTO") in connection with its delay in filing its audited annual financial statements (the "Financial Statements"), management's discussion and analysis ("MD&A") and related Chief Executive Officer and Chief Financial OfMedical First: Germany Strengthens Reimbursement of Medical Cannabis
On 16 March 2023, after five years of observational data collection the German Federal Joint Committee (G-BA) decided on the future regulations that will govern the prescription of medical cannabis as a benefit of the statutory health insuranceAfter several months of discussions and thoroughly analyzing the data, the G-BA passed regulations that ensure patient care with medical cannabis and coverage by statutory health insuranceGermany is the largest and fastest growing medical cannabis market..
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Khiron Life Sciences
Sign Up For FreeTo access detailed company insights
Khiron is a leading vertically integrated medical cannabis company with core operations in Latin America and Europe. Leveraging wholly-owned medical health centres and proprietary telemedicine platforms, Khiron combines a patient-oriented approach, physician education programs, scientific expertise, product innovation, and agricultural infrastructu... Read More
